RxDoctor Payments Data

Connie Bentley, APRN

Nurse Practitioner · Tyler, TXNPI 1447243571

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 95.7% of it on its own, with 7 other manufacturers making up the rest. 2024 is the largest year on record at $3,211, more than ten times the $55 reported in 2021. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,756in general payments, 2019–2025

Across 34 payments — averaging $228.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$7K
  • Tersera Therapeutics LLC$199
  • AbbVie$38
  • Lilly USA, LLC$28
  • Amgen$21
  • Innovation Technologies Inc$19
  • plus $26 from 2 others

What the payments were for

  • Consulting fees$3,31343%
  • Speaking & faculty fees$1,74522%
  • Travel & lodging$1,45219%
  • Food & beverage$1,06914%
  • Education$1772%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,756 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Medicare billing

Part B allowed, 2024
$43,645
Medicare patients
141
Services billed
565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl12$656
Gabapentin12$177
Tizanidine Hcl12$130
Ondansetron Hcl12$70

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Tyler

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →